BEGIN TYPING YOUR SEARCH ABOVE AND PRESS RETURN TO SEARCH. PRESS ESC TO CANCEL
International Journal of Cardiology – Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientificdata

International Journal of Cardiology – Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientificdata

This is the article published in the International Journal of Cardiology 220 (2016) 589–594.

International Journal of Cardiology – Treatment of bifurcation lesions with drug-coated balloons: A review of currently available scientificdata

Bernardo Cortese (a,b,⁎), Davide Piraino (c), Dario Buccheri (a,c), Fernando Alfonso(d)
(a) Interventional Cardiology, A.O. Fatebenefratelli Milano, Italy
(b) Fondazione Monasterio CNR-Regione Toscana, Italy
(c) Interventional Cardiology,“P.Giaccone”Universitary Hospital of Palermo, Italy
(d) Interventional Cardiology, Hospital Universitario de La Princesa, Spain
(⁎) Corresponding author at: Interventional Cardiology, A.O. Fatebenefratelli Milano, Bastioni di Porta Nuova 21, 20100 Milano, Italy. E-mail address:bcortese@gmail.com (B. Cortese)

Conclusion

DCB use for bifurcation lesion management remains very attractive indeed as a complement of a provisional stenting strategy. However, currently available scientific evidence remains scarce and we still require additional data to refine its real clinical value. However, an indiscriminate use of stents in this setting (complex stenting or any 2-stent technique) is associated with suboptimal Clinical and angiographic results. The use of a novel generation DES in the MB remains the strategy of choice for most patients that can be managed with a provisional stenting strategy. It is possible that newer technologies such as DCB and biovascular scaffolds might improve the short and long-term outcome of bifurcation lesions, allowing a limited use of permanent prosthesis, especially at the SB

DCB bifurcation review 16

Leave a comment